Haloperidol Lactate Injection, Solution
Product Images NDC 55154-7076

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol Lactate (NDC 55154-7076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure diagram of Haloperidol Lactate, showing its molecular configuration with fluorine and chlorine substituents on aromatic rings.*
FDA Label Image

5mg/ml Bag Label (11dd6850 9fda 4f26 B107 3f242d7a0d35 00)

5mg/ml Bag Label (11dd6850 9fda 4f26 B107 3f242d7a0d35 00)
The label provides detailed drug facts for Haloperidol Injection, USP 5 mg/mL for immediate release. It includes dosage form as 5 x 1 mL single-dose vials for intramuscular use, active ingredients, preservatives, storage instructions, warnings, and manufacturing details for Mylan Institutional LLC, distributed by Cardinal Health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.